Warburg Pincus invested $300m in Vertice Pharma.

Private equity firm Warburg Pincus invested $300m in Vertice Pharma, a specialty pharmaceuticals company. Fred Hassan, Managing Director, Healthcare, Warburg Pincus, added, "There is an opportunity in this sector to create significant value in key branded and generic assets by investing in development to drive revenues and improving operations. Don, Andrew and the rest of the Vertice Pharma team are the ideal partners to do just that and we look forward to supporting them."